HiLabs
PrivateLast Round
Series B
Mar 14, 2024
Est. Valuation
$150M
Total Funding Raised
$39.25M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
HiLabs operates in Healthcare & Life Sciences and is based in Bethesda, Maryland. Its latest recorded funding round was a Series B round in March 2024.
HiLabs is a healthcare technology company that provides an AI-powered platform to clean, standardize, and enrich provider data for health plans and healthcare organizations.
Sector
Healthcare & Life Sciences
Verticals
Healthcare Analytics, Data Governance, Medical AI, NLP & Conversational AI, Compliance
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
HiLabs Comparables
Compare HiLabs with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| H1 | 88% | |
| CertifyOS | 86% | |
| Quest Analytics | 84% |
For institutional investors. Book with your work email.
HiLabs Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 14, 2024 | ||||
| Seed | Oct 27, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
HiLabs Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| F-Prime Capital | Series B |
| Eight Roads Ventures | Series B |
| Denali Growth Partners | Series B |
| F-Prime Capital | Series B |
| Season Two Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors grew 109% MoM, reaching 23K.
- May 7, 2026
5 of the top 10 U.S. health plans are now customers.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- has_revenueSep 2, 2026
HiLabs Inc. reaches $42.1M in revenue in 2025.
- recognized_asSep 1, 2026
On Sep 1st '26, HiLabs Inc. achieves HITRUST e1 Certification and HITRUST AI Security Certification for its MCheck(R) platform in District of Columbia, with HITRUST certifications validating its cybersecurity, compliance, and AI-specific risk management controls.
- recognized_asAug 12, 2026
Inc. names HiLabs Inc. to the Inc. 5000 list for the second consecutive year, recognizing it in the annual ranking of America's fastest-growing private companies in Washington on Aug 12th '26.
For institutional investors. Book with your work email.
HiLabs Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about HiLabs's valuation, stock price, and market status.
Is HiLabs a public or private company?
HiLabs is a private company.
What is the current stock price of HiLabs?
HiLabs is a private company, so its shares have no public market price. Caplight tracks HiLabs's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is HiLabs worth (valuation)?
HiLabs's valuation is estimated at $150.0M based on funding round data.
Can I buy HiLabs stock?
HiLabs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was HiLabs's last funding round?
HiLabs's most recent funding round was Series B on March 14, 2024.
Who are the main investors in HiLabs?
Key investors in HiLabs include Eight Roads Ventures, Denali Growth Partners.
Will HiLabs IPO soon?
No public IPO plans have been announced for HiLabs.
How can I track HiLabs secondary market activity?
Caplight tracks bids, offers, and trades in HiLabs's shares on secondary markets.